Adaptimmune Therapeutics PLC Sponsored ADR Forecast, price target & analysts
Adaptimmune Therapeutics PLC Sponsored ADR Target price 2026 - Analyst rating & recommendation
Adaptimmune Therapeutics PLC Sponsored ADR Classifications & Recommendation
Adaptimmune Therapeutics PLC Sponsored ADR Price Target
| Target Price | $0.28 |
| Price | $0.03 |
| Potential | |
| Number of Estimates | 4 |
| 4 Analysts have issued a price target Adaptimmune Therapeutics PLC Sponsored ADR 2027 . The average Adaptimmune Therapeutics PLC Sponsored ADR target price is $0.28. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 9 analysts: 0 Analysts recommend Adaptimmune Therapeutics PLC Sponsored ADR to buy, 5 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Adaptimmune Therapeutics PLC Sponsored ADR stock has an average upside potential 2027 of . Most analysts recommend the Adaptimmune Therapeutics PLC Sponsored ADR stock at Hold. |
Sales and Margin forecast 2025, 2026 to 2032
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
7 Analysts have issued a sales forecast Adaptimmune Therapeutics PLC Sponsored ADR 2025 . The average Adaptimmune Therapeutics PLC Sponsored ADR sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
3 Analysts have issued an Adaptimmune Therapeutics PLC Sponsored ADR EBITDA forecast 2025. The average Adaptimmune Therapeutics PLC Sponsored ADR EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
7 Adaptimmune Therapeutics PLC Sponsored ADR Analysts have issued a net profit forecast 2025. The average Adaptimmune Therapeutics PLC Sponsored ADR net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? |
7 Analysts have issued a Adaptimmune Therapeutics PLC Sponsored ADR forecast for earnings per share. The average Adaptimmune Therapeutics PLC Sponsored ADR EPS is
. This is than earnings per share in the financial year 2024. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Adaptimmune Therapeutics PLC Sponsored ADR...
Current Adaptimmune Therapeutics PLC Sponsored ADR Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| ??? |
Locked
➜
Locked
|
Locked | ??? |
| Analyst Rating | Date |
|---|---|
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
|
Locked
???:
Locked
➜
Locked
|
??? |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
